SEATTLE, Oct. 13 /PRNewswire/ -- Larry Corey, M.D., senior vice president
and co-director of the Vaccine and Infectious Disease Institute at Fred
Hutchinson Cancer Research Center, today was named as one of 65 new members of
the prestigious Institutes of Medicine (IOM).
Election to the IOM is considered one of the highest honors in the fields
of health and medicine and recognizes individuals who have demonstrated
outstanding professional achievement and commitment to service. Members are
elected through a highly selective process that recognizes people who have
made major contributions to the advancement of the medical sciences, health
care, and public health.
"I am honored by the recognition," Corey said. With a tip of the hat to
those who work in his labs, Corey added, "I thank all of the smart fellows,
post docs, technicians and collaborators who have made me look so good over
the years. I hope I continue to stay out of their way and allow them to pursue
their ideas, with just the right touch of guidance from me."
With their election to the IOM, members make a commitment to volunteer a
significant amount of time to IOM committees, which engage in a broad range of
studies on health policy issues.
Corey is principal investigator of the HIV Vaccine Trials Network, which
is based at the Hutchinson Center. He is also head of the University of
Washington's Virology Division and is a professor of medicine and laboratory
medicine at the UW School of Medicine.
Research in Corey's labs includes studies dealing with the pathogenesis,
prevention and treatment of HIV and herpes virus infections. These
investigations include the development of experimental vaccines for both
genital herpes and HIV. The labs have also pioneered novel tests for
diagnosing and monitoring therapies for viral infections.
.gif)
